PEDRO PABLO
ESPAÑA YANDIOLA
Investigador hasta 2024
Hospital Universitari de Bellvitge
l'Hospitalet de Llobregat, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitari de Bellvitge (11)
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)
Nature
-
Persistent Respiratory Failure and Re-Admission in Patients with Chronic Obstructive Pulmonary Disease Following Hospitalization for COVID-19
International Journal of COPD, Vol. 18, pp. 2473-2481
-
Residual pulmonary infiltrates, symptoms and diffusion impairment at 1-year after severe COVID-19 infection have different associated factors
Journal of Internal Medicine, Vol. 294, Núm. 1, pp. 69-82
2022
-
Detailed stratified GWAS analysis for severe COVID-19 in four European populations
Human Molecular Genetics, Vol. 31, Núm. 23, pp. 3945-3966
2021
-
Mapping the human genetic architecture of COVID-19
Nature, Vol. 600, Núm. 7889, pp. 472-477
2016
-
High Body Mass Index as a Risk Factor for Hospitalization Due to Influenza: A Case-Control Study
Archivos de Bronconeumologia, Vol. 52, Núm. 6, pp. 299-307
2014
-
Predictive factors of severe multilobar pneumonia and shock in patients with influenza
Emergency Medicine Journal, Vol. 31, Núm. 4, pp. 301-307
2013
-
Risk factors and effectiveness of preventive measures against influenza in the community
Influenza and other Respiratory Viruses, Vol. 7, Núm. 2, pp. 177-183
2012
-
Effectiveness of hand hygiene and provision of information in preventing influenza cases requiring hospitalization
Preventive Medicine, Vol. 54, Núm. 6, pp. 434-439
-
Prognosis of hospitalized patients with 2009 H1N1 influenza in Spain: Influence of neuraminidase inhibitors
Journal of Antimicrobial Chemotherapy, Vol. 67, Núm. 7, pp. 1739-1745